Abstract
The global burden of atherothrombotic diseases continues to grow. Worldwide, 17.9 million deaths per year are caused by cardiovascular diseases (CVD). According to WHO estimates, this number is expected to grow to more than 23.6 million by 2030. To achieve a more effective primary prevention of cardiovascular morbidity and mortality, the development of new diagnostic and therapeutic strategies is required. Nanomedicine offers a unique platform for novel approaches to the diagnosis and therapy of CVD. In particular iron oxide-based magnetic nanoparticles, a class of nanosized agents with superparamagnetic properties, are considered a promising tool in management of cardiovascular patients. Their possible applications range from plaque imaging and thrombus detection to the targeted drug-delivery, stent endothelialisation and blood vessel regeneration. This paper summarizes recent advances in the implementation of magnetic nanoparticles to diagnosis and treatment of cardiovascular disorders.
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
